Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells
2005
Valproic Acid and Notch Signaling in Neuroblastoma Cells
publication
Evidence: moderate
Author Information
Author(s): Stockhausen M-T, Sjölund J, Manetopoulos C, Axelson H
Primary Institution: Lund University, University Hospital MAS, Malmö, Sweden
Hypothesis
Can valproic acid influence Notch signaling and differentiation in neuroblastoma cells?
Conclusion
Valproic acid enhances Notch signaling and promotes differentiation and cell death in neuroblastoma cells.
Supporting Evidence
- Valproic acid treatment led to increased cell death and differentiation in neuroblastoma cells.
- Notch signaling was activated in neuroblastoma cells treated with valproic acid.
- Valproic acid functions as a histone deacetylase inhibitor, which may contribute to its effects on neuroblastoma cells.
Takeaway
Valproic acid, a medicine usually for epilepsy, helps brain cancer cells grow up and die when tested in the lab.
Methodology
The study involved treating neuroblastoma cell lines with valproic acid and analyzing changes in Notch signaling and cell differentiation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website